argenx to acquire Forte Biosciences for $2.2 billion

July 27, 2026 1:00 AM

argenx (Euronext & Nasdaq: ARGX) has agreed to acquire Forte Biosciences, Inc. (Nasdaq: FBRX) through a cash tender offer of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found